
UKHSA warns 'know the symptoms' of 'highly contagious' disease
The UK Health Security Agency wants people to familiarise themselves with the symptoms of the 'serious' disease
The UK Health Security Agency (UKHSA) wants people to recognise the symptoms of a "highly contagious" disease. Knowing the warning signs is key, as the disease"can cause serious complications."
The government agency issued a social media alert about measles, urging people to get fully vaccinated. A post on X read: "#Measles is highly contagious and can cause serious complications. It's easily preventable with the #MMR vaccine, so make sure that you and your loved ones are up to date and catch up on any missed doses." It included a video urging people to "know the symptoms."
UKHSA said the first symptoms of measles include:
high temperature
runny or blocked nose
sneezing
a cough
red, sore, watery eyes
These symptoms are followed by a rash that starts on the face then spreads to the rest of the body. UKHSA said: "The rash looks brown or red on white skin. It may be harder to see on brown and black skin. Some people may also get small spots in their mouth."
The NHS website has photos that show what the rash could look like on your skin. The rash usually appears a few days after you get the cold-like symptoms.
The guidance explained that you should phone ahead before visiting your GP surgery if you suspect measles, as your GP may suggest talking over the phone.
Information about the MMR vaccine can be found on the NHS website. The NHS explains: "The MMR vaccine gives long-term protection against measles, mumps and rubella." It adds: "These 3 infections spread easily between people and can lead to serious problems including meningitis, blindness and hearing loss.
"If you're pregnant, getting measles can cause premature birth, miscarriage or still birth. And getting rubella can cause serious problems for your baby such as damage to their sight and hearing.
"2 doses of the MMR vaccine gives you long-term protection. Getting vaccinated also helps protect people who cannot be vaccinated, such as unborn babies, newborn babies and anyone with a weakened immune system."
Babies and young children are usually given the MMR vaccine as part of the NHS vaccination schedule, but older children and adults can have it if they were not vaccinated, as it can be given at any age.
While most people can have the MMR vaccine, the NHS advises it is not suitable if you're pregnant, have a weakened immune system, or have had a serious allergic reaction to ingredients in the vaccine, reports Bristol Live.
If you think you might need the MMR vaccine or you're not sure if your child has had both doses, the NHS says to contact your GP surgery. The vaccine is given as an injection in the upper arm or thigh, and it is usually delivered at least one month apart for adults. Young children have the first dose they're 1 year old and the second dose when they're between 3 years 4 months and 5 years old. Both doses are necessary for full protection.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mirror
44 minutes ago
- Daily Mirror
UKHSA issues urgent health warning after walking outdoors
People have been urged to look out for ticks, small creatures that can carry a number of infections. Brits have been issued an urgent warning to take care when walking outdoors this summer due to a serious risk to health. The UK Health Security Agency (UKHSA) has shared guidance on how to stay safe from ticks. Ticks are tiny, spider-like creatures that live in undergrowth and latch on to animals including humans when they walk through long grass. They are becoming more prevalent in parts of the UK, mainly due to increasing numbers of deer. While feeding, they can transmit viruses and infections that cause disease, with the most common being Lyme disease. In a post made to X, the UKHSA said: 'Summer's a great time to get outside, but ticks love the outdoors too. 'If you're walking through grassy or wooded areas, take a look at our guidance to help you stay safe and be tick aware.' In an infographic, it explained what to do if you find a tick on your body. What to do if you've been bitten by a tick 'Remove ticks as soon as you find them,' it said. 'If you have a tick removal device, follow its instructions or use a pair of fine-tipped tweezers.' Next you need to grasp the tick 'as close to the skin as you can'. The UKHSA explained: 'Pull upwards firmly, making sure all of the tick is removed.' You then need to clean the bite area with soap and water, and keep an eye on it for a few weeks in case of 'any changes' The health authority warned: 'Look out for a spreading bullseye rash, which is a common symptom of Lyme disease three to 30 days after being bitten. 'If you become unwell, for example with a spreading circular rash, flu-like symptoms, nerve pain or a droop on one or both sides of the face within a few weeks of a tick bite, call your GP practice or NHS 111.' Other potential symptoms of Lyme disease include: A high temperature, or feeling hot and shivery Headache Muscle and joint pain Tiredness and loss of energy The NHS warns that some people who are diagnosed and treated for Lyme disease continue to have symptoms, like tiredness, aches and loss of energy, that can last for years. 'These symptoms are often compared to fibromyalgia and chronic fatigue syndrome,' it says. 'It's not clear why this happens to some people and not others. This means there's also no agreed treatment.' You should speak to a doctor if your symptoms come back, or do not improve, after treatment with antibiotics. To reduce the risk of being bitten by a tick in the first place, the NHS recommends you:


The Independent
an hour ago
- The Independent
Thousands of NHS patients ‘to be denied breakthrough Alzheimer's drugs'
Breakthrough drugs that slow the progression of Alzheimer's disease will reportedly be refused for use on the NHS this week in a blow to thousands of patients. The two drugs, Lecanemab and donanemab, slow down the decline in Alzheimer's patients' ability to carry out daily activities. The drugs' success in halting the progression of Alzheimer's was heralded as a 'new era' by campaigners and researchers. However, the National Institute for Health and Care Excellence (Nice) is expected to refuse to recommend them on the NHS, according to The Sunday Times. The regulator has already issued two decisions, one in October last year and another in March, saying they would not recommend the drugs for use on the NHS. A final decision will be published on Thursday. Both drugs already have UK drug licences, making them available privately. It is estimated that around 70,000 adults in England would have been eligible for treatment if the drugs had been approved. The regulator will reportedly turn down both drugs on the grounds of cost-effectiveness, with one insider telling The Sunday Times: 'It is the end of the road for these drugs on the NHS'. Lecanemab removes build-ups of the protein beta-amyloid from the brain. Trials showed that lecanemab can slow the progression of Alzheimer's by 27 per cent over 18 months if given to someone early on in the course of their decline. Donanemab, marketed as Kisunla in the UK, teaches the body's immune cells to recognise and remove the amyloid protein, which builds up in the brains of people with Alzheimer's disease. The protein build-ups are thought to be toxic to brain cells, leading to the symptoms of Alzheimer's, the Alzheimer's society has said. Lecanemab can, however, cause swelling and bleeding in the brain. In trials for Donanemab, a third of recipients experienced abnormalities in their brain scans caused by brain swelling and bleeding, NICE said. The drugs reportedly cost around £20,000 to £25,000, with the NHS being offered a lower price. Privately, the treatment costs between £60,000-80,000 per year, according to Alzheimer's Research UK. In a previous review by NICE in October 2024, director of medicines evaluation Helen Knight said: 'Donanemab could slow down cognitive decline by 4-7 months, but this is just not enough benefit to justify the additional cost to the NHS. The cost-effectiveness estimate for donanemab is five to six times above what NICE normally considers an acceptable use of NHS resources'. While the regulator said the decision would be disappointing for some, 'there are other treatments being developed'. Hilary Evans-Newton, chief executive of Alzheimer's Research UK, said the decision to turn down the drugs would be 'deeply disappointing'. She added: 'These treatments are not perfect, and we recognise the challenges they pose around cost, delivery and safety. But scientific progress is incremental, and these drugs represent a vital foundation to build on.' The regulator NICE is due to publish the final draft guidance about the two drugs on Thursday. This leaves space for the decision to be challenged and sent to a review panel before the final guidance is published.


BBC News
2 hours ago
- BBC News
Herne Bay man has bladder tumours treated as NHS outpatient
A father-of-four has had bladder tumours removed as an outpatient at a Kent hospital through a pioneering new Payne, from Herne Bay, watched on-screen as surgeons removed a small tumour from his bladder via a procedure known as trans urethral laser 67-year-old, who underwent the procedure last week at Kent and Canterbury Hospital, says he was "absolutely blown over by the experience and the technology".Mr Payne had a previous tumour removed under general anaesthetic four years ago at an East Kent Hospitals University NHS Foundation Trust hospital. He said he was "a little bit nervous" before undergoing the new procedure, as he feared it might not be as effective."But it was exactly the same, just without the general anaesthetic," he said."I watched it on screen. I could see everything, and it was just like watching a documentary. I was even able to direct the consultant to where the tumour was." 'Major step forward' The procedure saw lead consultant for superficial bladder cancer, Georgios Papadopoulos, insert a thin flexible tube with a camera and light into Mr Payne's then took biopsies of the tumour before it was removed using a laser. Any remaining cancer cells were killed using chemotherapy. Mr Papadopoulos said: "This is a major step forward in how we treat patients with small tumours in their bladder."The Prostate Cancer Support Association Kent donated two laser machines, while the League of Friends of the Kent and Canterbury Hospital also helped provide funding.